# Hippocratic AI

> Hippocratic AI builds safety-focused generative AI agents for non-diagnostic, patient-facing clinical work - voice-based agents that handle care coordination, chronic disease check-ins, medication adherence, and patient education. Its Polaris constellation architecture coordinates dozens of specialized LLMs to keep conversations clinically safe, with humans escalating where needed.

- **Founded:** 2023
- **Headquarters:** Palo Alto, California, United States
- **Founders:** Munjal Shah (Co-founder & CEO), Vishal Naik (Co-founder & Chief Product Officer), Subhabrata Mukherjee (Co-founder & Chief Science Officer)
- **Team size:** ~300
- **Products:** Polaris, Generative AI Healthcare Agents, Healthcare Agent Marketplace
- **Notable:** 115M+ patient interactions completed with zero reported safety incidents, Reached unicorn status in 2025 (Series B at $1.6B), then $3.5B at Series C, Built 1,000+ clinical use cases in the first 15 months of commercialization

## Products & services

- **Polaris** — A safety-focused constellation of LLMs (the latest, Polaris 3.0, spans 22+ specialist agents) that powers real-time, voice-based patient conversations.
- **Generative AI Healthcare Agents** — Voice agents for chronic care management, post-discharge follow-up, medication adherence, pre-op prep, social determinants screening, and patient navigation - non-diagnostic by design.
- **Healthcare Agent Marketplace** — A marketplace where health systems can deploy AI agents built on Hippocratic's safety-validated platform across clinical and operational workflows.

## Achievements

- 115M+ patient interactions completed with zero reported safety incidents
- Reached unicorn status in 2025 (Series B at $1.6B), then $3.5B at Series C
- Built 1,000+ clinical use cases in the first 15 months of commercialization
- Showcased by NVIDIA CEO Jensen Huang at GTC
- Recruited 1,100+ nurses and 130+ physicians for model training and validation

## Latest updates

- **2026-01** — BCG strategic collaboration announced to deploy agentic AI across biopharma and medtech.
- **2025-11** — Raised $126M Series C led by Avenir Growth at a $3.5B valuation.
- **2025** — Released Polaris 3.0, expanding to a constellation of 22+ cooperative specialist agents.
- **2025-01** — Closed $141M Series B led by Kleiner Perkins.

## Links

- Website: https://hippocraticai.com
- LinkedIn: https://www.linkedin.com/company/hippocratic-ai-health
- Twitter/X: https://twitter.com/hippocraticai
- YouTube: https://www.youtube.com/@HippocraticAI
- Facebook: https://facebook.com/hippocraticai/

---

Profile page: https://yespress.io/hippocratic-ai
Published by YesPress — https://yespress.io
Last updated: 2026-05-19